JAMP CLONIDINE TABLETS DIN 02564513
Health Canada record
| Active ingredient(s) | CLONIDINE HYDROCHLORIDE 0.2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C02AC01 CLONIDINE |
| Original market date | |
| Current status date | 09-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLONIDINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02569485 | AURO-CLONIDINE | AURO PHARMA INC | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Approved |
| 02569493 | AURO-CLONIDINE | AURO PHARMA INC | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Approved |
| 02538504 | CLONIDINE | SIVEM PHARMACEUTICALS ULC | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Marketed |
| 02538490 | CLONIDINE | SIVEM PHARMACEUTICALS ULC | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Marketed |
| 02540061 | CLONIDINE | SIVEM PHARMACEUTICALS ULC | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02528207 | JAMP CLONIDINE | JAMP PHARMA CORPORATION | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02564505 | JAMP CLONIDINE TABLETS | JAMP PHARMA CORPORATION | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Approved |
| 02524198 | MAR-CLONIDINE | MARCAN PHARMACEUTICALS INC | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02534738 | MINT-CLONIDINE | MINT PHARMACEUTICALS INC | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02462206 | MINT-CLONIDINE | MINT PHARMACEUTICALS INC | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Marketed |
| 02462192 | MINT-CLONIDINE | MINT PHARMACEUTICALS INC | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Marketed |
| 02515792 | SANDOZ CLONIDINE | SANDOZ CANADA INCORPORATED | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Marketed |
| 02515784 | SANDOZ CLONIDINE | SANDOZ CANADA INCORPORATED | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Marketed |
| 02516217 | SANDOZ CLONIDINE | SANDOZ CANADA INCORPORATED | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02046148 | TEVA-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Marketed |
| 02046121 | TEVA-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Marketed |
| 02304163 | TEVA-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Marketed |
| 02248732 | APO-CLONIDINE | APOTEX INC | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Cancelled Post Market |
| 00868949 | APO-CLONIDINE TAB 0.1MG | APOTEX INC | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Cancelled Post Market |
| 00868957 | APO-CLONIDINE TAB 0.2MG | APOTEX INC | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Cancelled Post Market |
| 00259527 | CATAPRES TAB 0.1MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Cancelled Post Market |
| 00291889 | CATAPRES TAB 0.2MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Cancelled Post Market |
| 02361302 | CLONIDINE | SANIS HEALTH INC | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Cancelled Post Market |
| 02361299 | CLONIDINE | SANIS HEALTH INC | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Cancelled Post Market |
| 02361310 | CLONIDINE | SANIS HEALTH INC | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Cancelled Post Market |
| 01910396 | CLONIDINE 0.1 | PRO DOC LIMITEE | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Cancelled Post Market |
| 00519251 | DIXARIT TAB 0.025MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Cancelled Post Market |
| 02358581 | NTP-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.1 MG | Cancelled Pre Market |
| 02358565 | NTP-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.025 MG | Cancelled Pre Market |
| 02358603 | NTP-CLONIDINE | TEVA CANADA LIMITED | Tablet | CLONIDINE HYDROCHLORIDE 0.2 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36703 | 2026-01-09 | Abbreviated New Drug Submission (ANDS) |
International API supply for CLONIDINE HYDROCHLORIDE
6 valid EDQM Certificates of Suitability from 6 holders. 7 active FDA Drug Master Files.
Request a quote for JAMP CLONIDINE TABLETS